Abstract
5-nitroimidazoles (5-NI) are pharmacologically diverse drugs used mainly for anaerobic and parasitic infections. Metronidazole is the most widely used 5-NI and has rare neurotoxic effects, including cerebellar and brainstem dysfunction, encephalopathy, and seizures. Other (5-NI) have been studied as hypoxic cell radiosensitizers but are limited by dose-dependent side effects. Nimorazole is in use in Denmark for head-and-neck cancer and is considered safe. No cases of nimorazole-induced neurotoxicity like Metronidazole encephalopathy have been published. In this case, we report a patient who developed toxic encephaloneuropathy during nimorazole radiosensitisation.
| Bidragets oversatte titel | A case of toxic encephaloneuropathy during treatment with nimorazole |
|---|---|
| Originalsprog | Dansk |
| Artikelnummer | V12240878 |
| Tidsskrift | Ugeskrift for Laeger |
| Vol/bind | 187 |
| Udgave nummer | 29 |
| Sider (fra-til) | 1-3 |
| Antal sider | 3 |
| ISSN | 0041-5782 |
| DOI | |
| Status | Udgivet - 14 jul. 2025 |
Emneord
- Humans
- Metronidazole/adverse effects
- Male
- Neurotoxicity Syndromes/etiology
- Radiation-Sensitizing Agents/adverse effects
- Middle Aged